Medicinal chemistry and therapeutic potential of CpG DNA
The observation that oligodeoxynucleotides containing CpG dinucleotides (CpG DNA) exhibit several immunological effects has led to their use as therapeutic agents and adjuvants for various diseases. Several CpG DNA drug candidates are currently being evaluated, either as monotherapies or as adjuvant...
Saved in:
Published in | Trends in Molecular Medicine Vol. 8; no. 3; pp. 114 - 121 |
---|---|
Main Authors | , |
Format | Book Review Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.03.2002
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The observation that oligodeoxynucleotides containing CpG dinucleotides (CpG DNA) exhibit several immunological effects has led to their use as therapeutic agents and adjuvants for various diseases. Several CpG DNA drug candidates are currently being evaluated, either as monotherapies or as adjuvants (with vaccines, antibodies, antigens and allergens), in preclinical and clinical trials against cancers, viral and bacterial infections, allergies and asthma. Knowledge gained from studies of the medicinal chemistry of CpG DNA has provided a basis for designing a second generation of CpG DNA agents with desirable cytokine-inducing and potent immunomodulatory activity. This article reviews recent progress in understanding the effects of CpG DNA, the medicinal chemistry of CpG DNA, and its possible therapeutic applications.
Oligonucleotides containing CpG dinucleotides exhibit immunological effects, which make them attractive for therapeutic applications. Advances in the medical chemistry of CpG DNA have now provided the basis for a second-generation of CpG DNA agents with cytokine induction and potent immunomodulaltory activity. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Review-3 content type line 23 ObjectType-Feature-3 ObjectType-Review-1 |
ISSN: | 1471-4914 1471-499X |
DOI: | 10.1016/S1471-4914(01)02264-X |